Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Axogen, Inc.AXGN · Entity 4297 | Chief Commercial Officer | February 15, 2019 | February 19, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Axogen, Inc.
Report date February 15, 2019 · Filed February 19, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,190 |
Ending reported balance
After 2019-02-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-02-15 · Grant · Acquired 3,859 · Balance 5,532 F1: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. Row 2 · 2019-02-15 · Tax withholding · Disposed 1,342 · Balance 4,190 F2: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria.
F2: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC | Axogen, Inc. AXGN · Entity 4297 | Tax withholdingCommon Stock | 1,342 | $17.57 | $23,578.94 |
DisclosureSEC source: 0001179110-19-002052 · edgar.xml · nonDerivative · entry 2 Gingrich Jon S. · CIK 0001711638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,190 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantCommon Stock | 3,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-002052 · edgar.xml · nonDerivative · entry 1 Gingrich Jon S. · CIK 0001711638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,532 F1 · shares: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. F1 · price: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 23:53 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantRestricted Stock Units · Derivative | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015739 · edgar.xml · derivative · entry 2 Gingrich Jon S. · CIK 0001711638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock. F3 · derivative.exercise_date: All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. F3 · derivative.expiration_date: All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 23:53 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantEmployee Stock Option (right to purchase) · Derivative | 32,600 | $0.00 Strike: $27.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015739 · edgar.xml · derivative · entry 1 Gingrich Jon S. · CIK 0001711638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,600 Underlying: Common Stock · 32,600 shares Expires 2027-12-18 F1 · derivative.exercise_date: All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 18, 2021 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 20:20 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantEmployee Stock Option (right to purchase) · Derivative | 115,000 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001179110-17-010417 · edgar.xml · derivative · entry 1 Gingrich Jon S. · CIK 0001711638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2027-07-17 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on July 17, 2021 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on July 17, 2018 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.